Europe-Japan Diagnostic Study for EGFR Testing
NCT01785888
·
clinicaltrials.gov ↗
COMPLETED
Status
1311
Enrollment
INDUSTRY
Sponsor class
Conditions
EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.
Sponsor
AstraZeneca